Polyphenols as Systems Modulators of the Gut‐Brain‐Liver Axis: A Narrative Review of Neuro‐Metabolic and Immunomodulatory Networks
Molecular Nutrition & Food Research · 2026-08 · 70 (15)
DOI: 10.1002/mnfr.70560 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 09.08.2026. Verfasst von Aftab Alam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Polyphenols, Liver, Brain, Gastrointestinal Tract. Die Arbeit nennt 200 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Abstract (Originalsprache)
Dietary polyphenols are gaining attention as regulators of gut‐brain‐liver (GBL) signaling in metabolic disease. The objective of this narrative review is to examine how polyphenols affect neuro‐metabolic and immune pathways across the gut‐brain‐liver axis in obesity, type 2 diabetes, and metabolic dysfunction‐associated steatotic liver disease. The review covers literature from 2000 to 2025 indexed in PubMed, Scopus, and Web of Science, with emphasis on mechanistic, multi‐omics, preclinical, and human studies. Most polyphenols show poor absorption in the gastrointestinal tract and depend on liver enzymes and intestinal microorganisms for conversion into active metabolites, including urolithins, phenyl‐γ‐valerolactones, equol, and other phenolic acids. These metabolites influence microbial composition, bile acid signaling, gut hormone secretion, and host processes related to oxidative stress, inflammation, energy balance, and mitochondrial function. In animal and cell models, polyphenols reduce hepatic fat accumulation, improve insulin sensitivity, strengthen gut barrier integrity, and lower endotoxemia. Human evidence remains limited, derived mainly from short‐term trials with considerable inter‐individual variability. This variability appears linked to metabotype, metabolic capacity, habitual diet, sex, and medication use. Overall, current evidence supports polyphenols as multi‐target regulators of gut‐brain‐liver communication. Larger, well‐designed clinical and translational studies are needed to confirm their therapeutic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Pharmacology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Förderung
- Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia
Zitieren
APA
Alam, A., & Jawaid, T. (2026). Polyphenols as Systems Modulators of the Gut‐Brain‐Liver Axis: A Narrative Review of Neuro‐Metabolic and Immunomodulatory Networks. Molecular Nutrition & Food Research, 70(15). https://doi.org/10.1002/mnfr.70560
Vancouver
Alam A, Jawaid T. Polyphenols as Systems Modulators of the Gut‐Brain‐Liver Axis: A Narrative Review of Neuro‐Metabolic and Immunomodulatory Networks. Molecular Nutrition & Food Research. 2026;70(15). doi:10.1002/mnfr.70560
BibTeX
@article{Alam2026,
author = {Alam, Aftab and Jawaid, Talha},
title = {Polyphenols as Systems Modulators of the Gut‐Brain‐Liver Axis: A Narrative Review of Neuro‐Metabolic and Immunomodulatory Networks},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {15},
doi = {10.1002/mnfr.70560}
}
EUVIMED